{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1234.43","meta":{"versionId":"11","lastUpdated":"2022-01-06T01:02:20.000-05:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"BEST System Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2022-01-06"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.43","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1234.43"}],"version":"20220106","name":"COVID19VaccineRxNormCodesForExposureIdentification","title":"COVID19 vaccine RxNorm codes for exposure identification","status":"active","experimental":false,"date":"2022-01-06T01:02:20-05:00","publisher":"BEST System Steward","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: COVID-19 vaccine RxNorm codes for identification of potential biologics-related adverse events.),(Data Element Scope: This value set may use a model element in the QDM category of Procedure/Intervention, Immunization, Medication, or Substance.),(Inclusion Criteria: COVID-19 vaccine RxNorm codes.),(Exclusion Criteria: None)","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","concept":[{"code":"2468235","display":"SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.1 MG/ML Injectable Suspension"},{"code":"2470234","display":"SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.2 MG/ML Injectable Suspension"},{"code":"2479835","display":"SARS-COV-2 (COVID-19) vaccine, vector - Ad26 100000000000 UNT/ML Injectable Suspension"},{"code":"2583743","display":"SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.05 MG/ML Injectable Suspension"}]}]},"expansion":{"identifier":"urn:uuid:20929e76-15c3-4bb4-9ecf-1275ce7ab6d0","timestamp":"2023-12-11T00:23:06-05:00","total":4,"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"2468235","display":"SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.1 MG/ML Injectable Suspension"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"2470234","display":"SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.2 MG/ML Injectable Suspension"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"2479835","display":"SARS-COV-2 (COVID-19) vaccine, vector - Ad26 100000000000 UNT/ML Injectable Suspension"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"2583743","display":"SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.05 MG/ML Injectable Suspension"}]}}